Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience.
作者信息
Cattaneo D, Pasina L, Conti F, Giacomelli A, Oreni L, Pezzati L, Bonazzetti C, Piscaglia M, Carrozzo G, Antinori S, Gervasoni C
机构信息
Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli-Sacco University Hospital, Milan, Italy.
Unit of Clinical Pharmacology, ASST Fatebenefratelli-Sacco University Hospital, Milan, Italy.
出版信息
J Endocrinol Invest. 2021 Dec;44(12):2849-2851. doi: 10.1007/s40618-021-01604-6. Epub 2021 May 30.
Abstract
摘要
相似文献
1
Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience.接受皮质类固醇治疗的COVID-19患者潜在药物相互作用的风险：单中心经验
J Endocrinol Invest. 2021 Dec;44(12):2849-2851. doi: 10.1007/s40618-021-01604-6. Epub 2021 May 30.
2
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions.SARS-CoV-2 住院患者的药物不良反应：一项病例系列研究，重点关注药物-药物相互作用。
Intern Emerg Med. 2021 Apr;16(3):697-710. doi: 10.1007/s11739-020-02586-8. Epub 2020 Dec 23.
3
Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies.波涛汹涌的水域：在未来的药物相关观察性研究中考虑新冠疫情期间药物使用变化的重要性。
Basic Clin Pharmacol Toxicol. 2021 May;128(5):649-651. doi: 10.1111/bcpt.13568. Epub 2021 Feb 19.
4
Corticosteroids in COVID-19: We Should Be Mindful of Their Acute Toxicities.新型冠状病毒肺炎中的皮质类固醇：我们应留意其急性毒性。
J Clin Pharmacol. 2021 Oct;61(10):1301-1302. doi: 10.1002/jcph.1936. Epub 2021 Jul 20.
5
Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE.使用抗新冠病毒研究性药物治疗癫痫患者：国际抗癫痫联盟以色列分会的建议
Isr Med Assoc J. 2020 Nov;11(22):665-672.
6
Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic.无严重心律失常的低住院率：COVID-19大流行期间对350例早期在家接受羟氯喹治疗患者的前瞻性调查。
J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):922-923. doi: 10.2459/JCM.0000000000001061.
7
Chloroquine in fighting COVID-19: good, bad, or both?氯喹在抗击 COVID-19 中的作用：好、坏，还是皆有？
Autophagy. 2020 Dec;16(12):2273-2275. doi: 10.1080/15548627.2020.1796014. Epub 2020 Jul 25.
8
Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug-drug interactions-comment.2019冠状病毒病住院患者的药物不良反应：一个关注药物相互作用的病例系列——评论
Intern Emerg Med. 2021 Apr;16(3):797-798. doi: 10.1007/s11739-021-02645-8. Epub 2021 Jan 31.
9
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions-reply.2019冠状病毒病住院患者的药物不良反应：以药物相互作用为重点的病例系列——回复
Intern Emerg Med. 2021 Apr;16(3):799-800. doi: 10.1007/s11739-021-02677-0. Epub 2021 Feb 26.
10
Anticholinergic risk: Use and limitations of anticholinergic scales.抗胆碱能风险：抗胆碱能量表的应用与局限性
Eur J Intern Med. 2015 Dec;26(10):e65-6. doi: 10.1016/j.ejim.2015.08.014. Epub 2015 Sep 10.
引用本文的文献
1
The evaluation of potential drug-drug interactions with antibiotics in hospitalized patients.住院患者中抗生素潜在药物相互作用的评估。
North Clin Istanb. 2024 Oct 1;11(5):398-405. doi: 10.14744/nci.2023.82473. eCollection 2024.
2
Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda.乌干达西南部姆巴拉拉市私人药店处方中潜在药物-药物相互作用的流行情况及相关因素。
BMC Pharmacol Toxicol. 2024 Jan 2;25(1):2. doi: 10.1186/s40360-023-00719-1.
3
Evaluation of the Drug-Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese Adults.评估富马酸恩曲他滨与细胞色素 P450 3A 底物在健康日本成年人中的药物相互作用潜力。
Clin Drug Investig. 2023 May;43(5):335-346. doi: 10.1007/s40261-023-01265-8. Epub 2023 May 12.
4
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.新冠病毒病（COVID-19）常用药物与抗结核药物之间潜在药物相互作用的预测：药物信息软件与计算技术数据的整合方法
Ther Adv Drug Saf. 2021 Aug 26;12:20420986211041277. doi: 10.1177/20420986211041277. eCollection 2021.
本文引用的文献
1
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.关于 COVID-19 和相关潜在药物相互作用导致病情恶化的合并症的荟萃分析。
Pharmacol Res. 2020 Nov;161:105250. doi: 10.1016/j.phrs.2020.105250. Epub 2020 Oct 13.
Zotero 插件